Oramed Pharmaceuticals Inc. (ORMP) vs Whitehawk Therapeutics, Inc. (WHWK)

Oramed Pharmaceuticals Inc. and Whitehawk Therapeutics, Inc. are both Biotechnology companies. Oramed Pharmaceuticals Inc. and Whitehawk Therapeutics, Inc. are of similar size ($173.9M and $173.3M). Whitehawk Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Oramed Pharmaceuticals Inc. trades at 1.0×. Oramed Pharmaceuticals Inc. grew revenue faster over the last twelve months: 347.8% against 16.5%. Across the 14 metrics below, Oramed Pharmaceuticals Inc. leads on 8 and Whitehawk Therapeutics, Inc. on 6.

Valuation

Metric ORMP WHWK Biotechnology median
P/E 0.96 n/m 8.50
P/S 41.54 8.65 9.71
P/B 0.53 1.31 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 28.95 1.85 9.21
Earnings yield 103.93% (38.62%) (33.15%)
Free cash flow yield (3.12%) (29.08%) (25.50%)

Profitability

Metric ORMP WHWK Biotechnology median
Gross margin 32.31% 88.72% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 73.90% (44.98%) (56.36%)
Return on assets 65.52% (42.60%) (48.04%)
Return on invested capital (3.40%) 0.00% 0.00%

Growth

Metric ORMP WHWK Biotechnology median
Revenue growth (TTM) 347.77% 16.51% 6.02%
EPS growth (last fiscal year) 412.50% 86.02% 30.26%
Revenue growth, 5-year CAGR (5.85%) (13.29%) 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ORMP WHWK Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 4.98 17.38 4.72
Net debt to EBITDA 8.41 1.26 0.96

Dividend

Metric ORMP WHWK Biotechnology median
Dividend yield 6.14% — 0.09%
Payout ratio 0.06 — —

Size

Metric ORMP WHWK Biotechnology median
Market cap 173.87m 173.31m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack